English中文

Offstream
news


Central Intelligence Agency

Central Intelligence Agency (CIA) Director John O. Brennan announces plans for a major restructuring and reorganization, including a focus on digital espionage (through the creation of the CIA Directorate of Digital Innovation). The plan will end some longstanding divisions, and create ten new centers that team analysts with operators, fostering collaboration and focus on a range of new security issues and threats, and replacing geographic division offices with hybrid mission centers modeled on the CIA Counterterrorism Center.

Food and Drug Administration

The U.S. Food and Drug Administration (FDA) approves the country's first biosimilar drug, Zarxio (Europe: 2009, as Zarzio), made by Novartis. Biosimilars are a relatively new class of drugs designed to pave the way for less expensive versions of the complex biologics drug class, and they are not synthesized from chemicals like other drugs, but are made from living cells. Some well known biologics include Remicade and Enbrel for autoimmune diseases, and Herceptin and Avastin for cancer. Zarxio, used to prevent infection in cancer patients receiving chemotherapy, is a close copy of Neupogen, made by Amgen.

U.S. Justice Department

The U.S. Justice Department charges two Vietnamese citizens (Quoc Nguyen and Giang Hoang Vu) and a Canadian (David-Manuel Santos Da Silva) with running a massive cyberfraud ring that stole one billion email addresses, then sent spam offering knockoff software products of Adobe Systems Inc with the hacking having occurred between February 2009 and June 2012. The victim breaches include a massive 2011 attack on email marketing firm Epsilon, a unit of Alliance Data Systems Corp. Although the other two are in custody, Nguyen remains at large. The charge against Da Silva is conspiracy to commit money laundering.